P. G. M. Van Der Valk

P. G. M. Van Der Valk's AcademicInfluence.com Rankings

Biology

#13289

World Rank

#16829

Historical Rank

Neuroscience

#2293

World Rank

#2356

Historical Rank

biology Degrees

Download Badge

Biology

P. G. M. Van Der Valk's Degrees

PhD Neuroscience University of Amsterdam
Masters Biology University of Amsterdam

Similar Degrees You Can Earn

Best Online Master's in Biology

Why Is P. G. M. Van Der Valk Influential?

(Suggest an Edit or Addition)

(See a Problem?)

P. G. M. Van Der Valk's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Inflammation in neurodegenerative diseases (2010) (1109)
Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability (1999) (731)
Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. (1993) (525)
Tissue distribution of the multidrug resistance protein. (1996) (497)
Inflammation in CNS neurodegenerative diseases (2018) (483)
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status (2013) (417)
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study (2020) (346)
Homogeneity of active demyelinating lesions in established multiple sclerosis (2008) (324)
Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. (2003) (320)
Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. (1996) (310)
Transfer of Central Nervous System Autoantigens and Presentation in Secondary Lymphoid Organs1 (2002) (289)
Extensive Hippocampal Demyelination in Multiple Sclerosis (2007) (281)
Expression of growth factors, growth‐inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis (1998) (281)
Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. (1999) (273)
Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. (2001) (273)
Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. (2008) (271)
Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. (1995) (233)
Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. (2000) (233)
Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. (1997) (222)
Postmortem verification of MS cortical lesion detection with 3D DIR (2012) (219)
Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? (2010) (219)
Doxorubicin gradients in human breast cancer. (1999) (213)
Receptor conversion in distant breast cancer metastases (2010) (209)
Enhanced number and activity of mitochondria in multiple sclerosis lesions (2009) (209)
CD163‐positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation (2005) (207)
Expression and Cellular Distribution of Multidrug Resistance–related Proteins in the Hippocampus of Patients with Mesial Temporal Lobe Epilepsy (2004) (203)
Interaction of fibroblasts and polymer surfaces: relationship between surface free energy and fibroblast spreading. (1983) (199)
Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. (2003) (198)
Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. (1996) (194)
The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions (2005) (191)
Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS (2000) (190)
Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops (1998) (187)
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions (1997) (185)
Sphingosine 1‐phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions (2010) (182)
Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. (2000) (182)
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. (2001) (181)
The Blood-Brain Barrier in Cortical Multiple Sclerosis Lesions (2007) (173)
Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. (1997) (170)
Multidrug resistance related molecules in human and murine lung. (2002) (168)
Localization of Breast Cancer Resistance Protein (BCRP) in Microvessel Endothelium of Human Control and Epileptic Brain (2005) (165)
Hypoxia‐inducible factor‐1α is associated with angiogenesis, and expression of bFGF, PDGF‐BB, and EGFR in invasive breast cancer (2005) (165)
Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. (2009) (162)
Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation (2012) (160)
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons (2013) (158)
Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. (2007) (155)
Preactive lesions in multiple sclerosis (2009) (150)
Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis (2015) (148)
Survival of human glioma cells treated with various combination of temozolomide and X-rays. (2000) (147)
Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions (2012) (146)
Multidrug resistance gene (P-glycoprotein) expression in the human fetus. (1992) (145)
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. (2009) (144)
Differential expression of the c‐kit proto‐oncogene in germ cell tumours (1995) (144)
Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus-positive and -negative Hodgkin's disease. (1996) (139)
Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients. (2001) (139)
Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. (1999) (136)
Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions (2002) (136)
Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. (2005) (135)
Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids. (2001) (135)
Hypothalamic Lesions in Multiple Sclerosis (2001) (125)
Expression of drug resistance proteins in breast cancer, in relation to chemotherapy (1997) (124)
Cellular localization and expression patterns of interleukin‐10, interleukin‐4, and their receptors in multiple sclerosis lesions (2002) (122)
Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. (2000) (122)
Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier (2012) (117)
Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. (1999) (114)
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. (2010) (114)
Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. (2001) (111)
Major vault protein LRP-related multidrug resistance. (1996) (110)
Meningeal Inflammation is not Associated With Cortical Demyelination in Chronic Multiple Sclerosis (2009) (110)
Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis (2011) (108)
Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. (1990) (107)
ALK‐negative anaplastic large‐cell lymphoma demonstrates similar poor prognosis to peripheral T‐cell lymphoma, unspecified (2003) (105)
Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. (1994) (103)
Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization (1997) (102)
Retinoblastoma: MR imaging parameters in detection of tumor extent. (2005) (101)
p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. (1996) (101)
Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. (1995) (101)
Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis (2012) (96)
Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer (2009) (95)
&agr;B-Crystallin Is a Target for Adaptive Immune Responses and a Trigger of Innate Responses in Preactive Multiple Sclerosis Lesions (2010) (94)
Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. (1994) (92)
CNS myelin induces regulatory functions of DC-SIGN–expressing, antigen-presenting cells via cognate interaction with MOG (2014) (91)
What drives MRI-measured cortical atrophy in multiple sclerosis? (2015) (91)
Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. (2004) (89)
Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions (2001) (89)
Upregulation of Immunoglobulin‐related Genes in Cortical Sections from Multiple Sclerosis Patients (2009) (89)
CX3CL1 and CX3CR1 Expression in Human Brain Tissue: Noninflammatory Control versus Multiple Sclerosis (2003) (87)
Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases (2012) (85)
Prognostic relevance of P-glycoprotein expression in breast cancer. (1995) (84)
Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue. (2000) (82)
Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond. (2012) (82)
Vascular colocalization of P‐glycoprotein, multidrug‐resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies (2006) (79)
Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis. (2011) (78)
Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experience. (2006) (75)
BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. (1995) (73)
Increased expression of distinct galectins in multiple sclerosis lesions (2011) (72)
Expression and localization of inhibitor of apoptosis proteins in normal human tissues. (2006) (72)
Some characteristics of hyperoxia-adapted HeLa cells. A tissue culture model for cellular oxygen tolerance. (1985) (71)
Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. (1996) (69)
Matrix metalloproteinase‐19 is highly expressed in active multiple sclerosis lesions (2006) (69)
Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. (1994) (68)
The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro. (2002) (68)
Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung. (1995) (67)
Cholinergic imbalance in the multiple sclerosis hippocampus (2011) (65)
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis (2014) (65)
Isolation and culture of human bone marrow endothelial cells. (1995) (62)
Cutting Edge: Activity of Human Adult Microglia in Response to CC Chemokine Ligand 211 (2004) (62)
Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis. (1999) (62)
Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma? (1997) (61)
Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. (1993) (61)
Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. (2005) (61)
Neuronal and Axonal Loss in Normal-Appearing Gray Matter and Subpial Lesions in Multiple Sclerosis (2015) (61)
Immunohistochemistry in Bone Marrow Diagnosis: Value of a Panel of Monoclonal Antibodies on Routinely Processed Bone Marrow Biopsies (1989) (61)
Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. (2009) (60)
Diffuse signal abnormalities in the spinal cord in multiple sclerosis: Direct postmortem in situ magnetic resonance imaging correlated with in vitro high‐resolution magnetic resonance imaging and histopathology (2002) (59)
Pathology of multiple sclerosis. (2012) (59)
Differential Effects of Combined Ad5-Δ24RGD and Radiation Therapy in In vitro versus In vivo Models of Malignant Glioma (2007) (59)
Single-Shot Turbo Spin-Echo Diffusion-Weighted Imaging for Retinoblastoma: Initial Experience (2012) (58)
T lymphocytes impair P-glycoprotein function during neuroinflammation. (2010) (58)
Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues. (1996) (57)
The histology of reactive lymph nodes. (1987) (57)
Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group (2003) (57)
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself (2016) (57)
MLC1 is associated with the Dystrophin-Glycoprotein Complex at astrocytic endfeet (2007) (55)
Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. (2011) (55)
Heterogeneity of cortical lesions in multiple sclerosis (2012) (53)
A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) (53)
CD30 expression in normal and neoplastic lymphoid tissue: biological aspects and clinical implications. (1995) (52)
Association of Parkinson disease-related protein PINK1 with Alzheimer disease and multiple sclerosis brain lesions. (2011) (50)
Cytology, immunopathology and flow cytometry in the diagnosis of pleural and peritoneal effusions. (1988) (49)
Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression (2015) (49)
A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression (2016) (48)
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling (2015) (45)
Pediatric meningiomas in The Netherlands 1974–2010: a descriptive epidemiological case study (2012) (44)
Gene therapy for meningioma: improved gene delivery with targeted adenoviruses. (2002) (43)
Primary non-Hodgkin's lymphoma of the salivary glands. An analysis of 22 cases. (1996) (43)
Abundant extracellular myelin in the meninges of patients with multiple sclerosis (2009) (43)
Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings (2009) (43)
Morphometric characterisation of 52 B cell non-Hodgkin's lymphomas. (1983) (42)
Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous‐cell carcinoma, recognizes a CD44 isoform (1996) (42)
Stage is a better prognostic indicator than morphologic subtype in primary noncutaneous T-cell lymphoma. (1990) (41)
Activated microglia and cerebral amyloid deposits in Alzheimer's disease. (1992) (41)
Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil. (1994) (41)
Malignant lymphoma of mucosa-associated lymphoid tissue in the larynx (1998) (41)
Systemic Treatment of Malignant Thymoma: A Decade Experience at a Single Institution (2006) (40)
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis. (2014) (39)
Differentiation dependent expression of P-glycoprotein in the normal and neoplastic human kidney. (1991) (38)
Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions. (2013) (38)
Cortical Remyelination Is Heterogeneous in Multiple Sclerosis (2017) (37)
Simvastatin affects cell motility and actin cytoskeleton distribution of microglia (2006) (37)
Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions (2015) (36)
Opt-out plus, the patients’ choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment (2008) (36)
Morphometric characterization of diffuse large-cell (histiocytic) lymphomas. (1982) (36)
Transient Osteoporosis and Osteogenesis Imperfecta: A Case Report (1997) (35)
Appearance of Tissue Transglutaminase in Astrocytes in Multiple Sclerosis Lesions: A Role in Cell Adhesion and Migration? (2011) (35)
Elastase as a marker for neutrophilic myeloid cells. (1984) (35)
CC chemokine receptor 5 gene promoter activation by the cyclic AMP response element binding transcription factor. (2008) (34)
Immunohistochemical demonstration of different latent membrane protein-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases. (1995) (34)
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients (2014) (33)
Application and comparison of silver intensification methods for the diaminobenzidine and diaminobenzidine-nickel endproduct of the peroxidation reaction in immunohistochemistry and in situ hybridization. (1992) (33)
Brain lipid binding protein (FABP7) as modulator of astrocyte function. (2011) (32)
Phenotypic and genotypic analysis of large-cell lymphomas, formerly classified as true histiocytic lymphoma: identification of an unusual group of tumors. (1990) (32)
Retinoblastoma and optic nerve enhancement on MRI: not always extraocular tumour extension (2006) (31)
Attenuated AMPA Receptor Expression Allows Glioblastoma Cell Survival in Glutamate-Rich Environment (2009) (30)
Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay (2001) (30)
Myelin Basic Protein synthesis is regulated by small non‐coding RNA 715 (2012) (30)
Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. (1993) (30)
Expression of Growth Factors, Growth Factor Receptors and Apoptosis Related Proteins in Invasive Breast Cancer: Relation to Apoptotic Rate (2001) (30)
Angiotropic intravascular large-cell lymphoma with massive cerebral extension. (1993) (29)
Implementation of a multi‐institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture (2013) (29)
Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter (2015) (29)
Sjögren's syndrome with specific cutaneous manifestations and multifocal clonal T-cell populations progressing to a cutaneous pleomorphic T-cell lymphoma. (1989) (28)
Characterization of oxygen-tolerant Chinese hamster ovary cells. II. Energy metabolism and antioxidant status. (1988) (28)
Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses (2000) (28)
Contrast-Enhancement of the Anterior Eye Segment in Patients with Retinoblastoma: Correlation between Clinical, MR Imaging, and Histopathologic Findings (2010) (28)
The effects of ultrasonically induced hyperthermia on experimental tumors in the rabbit eye. (1989) (28)
Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas (2014) (27)
Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients? (2000) (26)
Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues. (1998) (26)
The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis (2011) (26)
Identification of novel drug resistance–associated proteins by a panel of rat monoclonal antibodies (1997) (26)
Neurotrophin receptor immunoreactivity in the hippocampus of patients with mesial temporal lobe epilepsy (2004) (25)
Analysis of large-cell lymphomas using monoclonal and heterologous antibodies. (1983) (25)
Pentraxin‐3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease (2016) (24)
Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas. (2016) (24)
Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain (2021) (23)
Noncutaneous T‐cell lymphomas recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis (1993) (23)
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer. (2001) (22)
Post-traumatic cutaneous meningioma (2004) (22)
Cortical Remyelination Is Heterogeneous in Multiple Sclerosis. (2017) (22)
Is Epstein–Barr virus present in the CNS of patients with MS? (2001) (22)
Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study (2015) (22)
Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: Preliminary experience (2004) (21)
Gene expression in the rat brain: High similarity but unique differences between frontomedial-, temporal- and occipital cortex (2011) (21)
Phagocytic potential of hairy cells. (2009) (20)
Retinoblastoma: Value of Dynamic Contrast-Enhanced MR Imaging and Correlation with Tumor Angiogenesis (2012) (20)
Combined modality therapy of gemcitabine and irradiation on human glioma spheroids derived from cell lines and biopsy tissue. (2006) (20)
Diagnostic Accuracy of Intraocular Tumor Size Measured with MR Imaging in the Prediction of Postlaminar Optic Nerve Invasion and Massive Choroidal Invasion of Retinoblastoma. (2016) (19)
MR Imaging Features of Retinoblastoma: Association with Gene Expression Profiles. (2018) (19)
Primary malignant lymphoma of the uterus: localization in a cervical polyp. (1993) (19)
Additive cytotoxic effect of cisplatin and X-irradiation on human glioma cell cultures derived from biopsy-tissue (2000) (19)
Cuprizone‐induced demyelination triggers a CD8‐pronounced T cell recruitment (2020) (19)
The epigenetics of multiple sclerosis and other related disorders. (2014) (17)
Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis (2018) (17)
Clonally related but phenotypically divergent human cancer cell lines derived from a single follicular thyroid cancer recurrence (TT2609). (2001) (16)
Retinal Dysplasia Mimicking Intraocular Tumor: MR Imaging Findings with Histopathologic Correlation (2007) (16)
Mucormycosis in a patient with low risk myelodysplasia treated with anti-TNF-alpha. (2006) (16)
Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer. (1998) (16)
The Apoptotic Paradox in Retinoblastoma (2009) (15)
Large cell lymphoma. II. Differential diagnosis of centroblastic and B‐immunoblastic subtypes by morphometry on cytologic preparations (1985) (14)
Sequential development of peripheral T‐cell lymphoma in the course of chronic myelogenous leukemia (1990) (14)
SARS-CoV-2 Infection Causes Dopaminergic Neuron Senescence (2021) (14)
Neurofilament light as an immune target for pathogenic antibodies (2017) (13)
Childhood Lymphomatoid Granulomatosis: A Report of 2 Cases and Review of the Literature (2014) (13)
Anaphylactoid reaction to intravenous methylprednisolone in a patient with multiple sclerosis (1997) (13)
Effect of single dose irradiation on human glioblastoma spheroids in vitro. (2004) (13)
Detection of Calcifications in Retinoblastoma Using Gradient-Echo MR Imaging Sequences: Comparative Study between In Vivo MR Imaging and Ex Vivo High-Resolution CT (2015) (13)
A Histopathological Contribution to Supratentorial Glioma Grading, Definition of Mixed Gliomas and Recognition of Low Grade Glioma With Rosenthal Fibers (2004) (13)
From a Suspicious Cystic Pineal Gland to Pineoblastoma in a Patient with Familial Unilateral Retinoblastoma (2014) (13)
Leukaemia cutis: clinical features and treatment strategies. (2002) (12)
Visual pathway neurodegeneration winged by mitochondrial dysfunction (2014) (12)
Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis (2013) (12)
Identification of highly connected hub genes in the protective response program of human macrophages and microglia activated by alpha B‐crystallin (2017) (12)
MR Imaging Features to Differentiate Retinoblastoma from Coats’ Disease and Persistent Fetal Vasculature (2020) (12)
Subcutaneous tumor seeding after biopsy in gliomatosis cerebri (2011) (12)
COVID‐19: Histopathological correlates of imaging patterns on chest computed tomography (2021) (12)
Adenolymphoma and non-Hodgkin's lymphoma of the salivary glands and oral cavity in immunocompetent patients are not associated with latent Epstein-Barr virus. (1997) (12)
Immunohistochemical studies of the spleen in hairy-cell leukemia. (1984) (11)
Multiple sclerosis as an “Inside‐out” disease (2010) (11)
Hairy cell leukemia: an immunohistochemic and morphometric study. (1984) (11)
Indoleamine 2,3‐dioxygenase (IDO)‐1 and IDO‐2 activity and severe course of COVID‐19 (2021) (10)
Multidrug resistance related proteins in primary cutaneous lymphomas. (1999) (10)
Histiocytic sarcoma. Clinical picture, morphology, markers, differential diagnosis. (1985) (10)
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients (2014) (9)
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases (2022) (9)
Biochemically silent sympathetic Paraganglioma, Pheochromocytoma or Metastatic Disease in SDHD mutation carriers. (2019) (9)
Differential Diagnosis of Cutaneous Large Cell Lymphomas Using Monoclonal Antibodies Reactive in Paraffin‐Embedded Skin Biopsy Specimens (1991) (9)
Immunohistochemical classification of B cell neoplasms (2003) (8)
"Borderline" giant cell tumor of the tendon sheath in the hand: to amputate or not? Case report. (1995) (7)
The revised European-American lymphoma (REAL) classification of non-Hodgkin's lymphoma: a missed opportunity? (1995) (7)
Retinoblastoma and retinal astrocytoma: unusual double tumour in one eye (2002) (7)
Mitotic synchrony in multinucleate Schizophyllum protoplasts. (1973) (7)
Oncolytic Virotherapy of Meningiomas in Vitro with Replication-competent Adenovirus (2005) (7)
Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2. (1992) (7)
Cutaneous histiocytic proliferations. (1985) (7)
Leukocyte functions. (1987) (6)
Endodermal sinus tumor of the maxillary sinus. (2001) (6)
Tracheobronchomalacia due to amyloidosis in a patient with rheumatoid arthritis (2008) (6)
Monoclonal antibodies in the histopathological diagnosis of non-Hodgkin lymphomas. (1985) (6)
T-cell lymphoblastic lymphoma of the lower jaw in a young child: a case report. (1996) (6)
Cardiac inflammation and microvascular procoagulant changes are decreased in second wave compared to first wave deceased COVID-19 patients (2021) (5)
Exposure of Microglia to Interleukin-4 Represses NF-κB-Dependent Transcription of Toll-Like Receptor-Induced Cytokines (2021) (5)
Immunohistochemical classification of T cell and NK cell neoplasms (2002) (5)
Has the Degree of Contrast Enhancement with MR Imaging in Laryngeal Carcinoma Added Value to Anatomic Parameters Regarding Prediction of Response to Radiation Therapy? (2007) (5)
The effects of irradiation on cell migration from glioblastoma multiforme biopsy spheroids. (2003) (4)
Endodermal Sinus Tumor of the Maxillary Sinus (2001) (4)
Re-irradiation of a second localization of idiopathic midline destructive disease in the head and neck area (2007) (4)
Features of proliferation and in vitro drug resistance in central primitive neuro‐ectodermal tumours (2002) (3)
Prion diseases: what will be next? (1998) (3)
A giant congenital orbital tumor: an unusual presentation of retinoblastoma. (1994) (3)
Immunopathology of the Optic Nerve in Multiple Sclerosis. (2022) (3)
Multiple neoplasms: A case report (2002) (3)
Poststreptococcal Myalgia and Myositis (2019) (3)
ACE2 Protein Expression During Childhood, Adolescence, and Early Adulthood (2022) (3)
Development and Internal Validation of a Multivariable Prediction Model for Adrenocortical-Carcinoma-Specific Mortality (2020) (2)
International retinoblastoma staging system helps to bridge the gap (2008) (2)
Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis (2013) (1)
Quality assurance in postgraduate pathology training the Dutch way: regular assessment, monitoring of training programs but no end of training examination (2016) (1)
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself (2016) (1)
Neutrophils as a pallbearer for SARS-CoV-2 disease burden – Authors’ reply (2021) (1)
Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient. (2019) (1)
MRI can reliably differentiate optic nerve inflammation from tumor invasion in retinoblastoma with orbital cellulitis. (2022) (1)
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status (2013) (1)
Dendritic reticulum cell sarcoma: a rare tumor of the follicular compartment. (1982) (0)
Expression and Cellular Distribution of Multidrug Resistance–related Proteins in the Hippocampus of Patients with Mesial Temporal Lobe Epilepsy (2004) (0)
Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas (2014) (0)
Cerebellar presence of immune cells in patients with neuro-coeliac disease (2023) (0)
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis (2014) (0)
Full-width postlaminar optic nerve tumor invasion of retinoblastoma as risk-factor for leptomeningeal spread of retinoblastoma. A case report and review of the literature (2020) (0)
Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier (2012) (0)
Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions (2015) (0)
Ultrastructural and biochemical properties of oxygen-resistant Chinese hamster ovary cells. (1984) (0)
Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter (2015) (0)
Bovisalm TM and Bovisalm D Vaccines are Safe and Prevent Salmonellosis in Calves (1992) (0)
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions (2015) (0)
Symptomatic unilateral sacroiliitis as a first presenting feature of IgG4-related disease with successful response to treatment after 1 year of follow-up article. (2016) (0)
Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation (2012) (0)